TD Securities Foresees Growth for Breast Implant Maker Amid GLP-1 Boom

Analysts predict Establishment Labs' stock could rise as expanding GLP-1 drug usage drives increased demand for associated medical devices and US market expansion.

2 Sept, 15:43 — 2 Sept, 15:43

Post Share

Sources

Showing 1 of 1 sources

cnbcMostly Factual16h ago

A breast implant maker's stock could climb as GLP-1 market booms, TD Securities says

Establishment Labs is poised to get a boost from widening GLP-1 use as it is set to expand its breast implant business in the U.S., per TD Securities.

Read full article →

TD Securities Foresees Growth for Breast Implant Maker Amid GLP-1 Boom

Sources

A breast implant maker's stock could climb as GLP-1 market booms, TD Securities says

Related Stories

Good Good Golf Ousts CEO and President Following Controversial Advertising Backlash

Elliott Management Takes Stake in Deutsche Telekom to Block T-Mobile Merger

Dutch Central Bank Moves 86 Tonnes of Gold from US, Canada to London

Trump Calls Iran Strikes Short-Lived as Regional Tensions Persist